




GFF, BCSI, CMED, AEZS, AMRI, WFR Expected To Be Down Before Next Earnings Releases
Published in Stocks and Investing on Friday, October 14th 2011 at 6:41 GMT by WOPRAI

October 14, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and November earnings reports. GRIFFON CORP (NYSE:GFF), BLUE COAT SYSTEMS INC (NASDAQ:BCSI), CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED), AETERNA ZENTARIS INC (NASDAQ:AEZS), ALBANY MOLECULAR RESEARCH (NASDAQ:AMRI), MEMC ELECTRONIC MATERIALS (NYSE:WFR) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down Before earnings are released Thursday:
Symbol Company # of Reports Quarter Release Date GFF GRIFFON CORP November Earnings Q4 11/17/2011 BCSI BLUE COAT SYSTEMS INC 6 Quarter Q2 11/17/2011 CMED CHINA MEDICAL TECH-SPON ADR 12 Quarter Q2 11/17/2011 AEZS AETERNA ZENTARIS INC November Earnings Q3 11/09/2011 AMRI ALBANY MOLECULAR RESEARCH November Earnings Q3 11/07/2011 WFR MEMC ELECTRONIC MATERIALS 6 Quarter Q3 11/02/2011This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
GRIFFON CORP (NYSE:GFF) - Griffon Corporation, through its subsidiaries, operates as a manufacturing company. The company operates through three segments: Telephonics, Building Products, and Plastics. The Telephonics segment specializes in advanced electronic information and communication systems for defense, aerospace, civil, industrial, and commercial applications. This segment designs, manufactures, sells, and provides logistical support for aircraft communication systems, radar, air traffic management, information and command and control systems, identification friend or foe equipment, integrated homeland security systems, and application specific integrated circuits. This segment also supplies airborne maritime surveillance radar and aircraft intercommunication management systems. The Building Products segment manufactures and markets garage doors and sectional doors for home remodeling, new residential housing, and commercial building markets under the Clopay, Ideal Door, and Holmes brand names. The Plastics segment develops and produces specialty plastic films and laminates, including thin gauge embossed and printed films, elastomeric films, and laminates of film and non-woven fabrics, which are used as moisture barriers in disposable infant diapers, adult incontinence products, and feminine hygiene products; as protective barriers in single-use surgical and industrial gowns, drapes, and equipment covers; and as packaging for hygienic products, house wrap, and other products. Griffon Corporation sells its products through direct sales force and sales representatives, as well as through installing dealers, retailers, and wholesalers. The company operates primarily in the United States, Germany, Canada, Brazil, and the United Kingdom. Griffon Corporation was founded in 1959 and is headquartered in New York, New York.
BLUE COAT SYSTEMS INC (NASDAQ:BCSI) - Blue Coat Systems, Inc. designs, develops, and sells products and services that secure and optimize the delivery of business applications and other information to distributed users over a wide area network (WAN) or the public Internet/Web. The companys products include ProxySG Appliance that serves as the foundation for secure Web gateway products and WAN Optimization offerings; ProxySG Virtual Appliance, a software that provides WAN optimization functionality; CacheFlow 5000 Appliance for telecommunications service providers; Blue Coat ProxyAV Appliance to use with ProxySG appliances to provide inline threat protection and malware scanning of Web content at the Internet gateway; and Blue Coat WebFilter Software, a content filtering database that operates on ProxySG appliance and includes client-based software for remote workers. Its products also include Blue Coat Reporter Software that collects data and generates pre-defined and custom reports to provide an IT administrator with better visibility into the enterprises Web-related user activity; Blue Coat Director Appliance, which enables an IT administrator to centrally manage an enterprises Blue Coat ProxySG appliances; Blue Coat PacketShaper Appliance that helps IT administrators to monitor applications running on the enterprises network to obtain information on its LAN/WAN/Internet traffic; Blue Coat IntelligenceCenter Software, which provides application performance monitoring for PacketShaper appliances deployed across the distributed enterprise; and Blue Coat PolicyCenter Software that helps IT administrators to centrally manage the configuration, policy management, software distribution, and adaptive response tracking of a distributed PacketShaper environment. The company was formerly known as CacheFlow, Inc. and changed its name to Blue Coat Systems, Inc. in August 2002. Blue Coat Systems was founded in 1996 and is headquartered in Sunnyvale, California.
CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED) - China Medical Technologies, Inc., a medical device company, develops, manufactures, and markets advanced immunodiagnostic and molecular diagnostic products primarily in the Peoples Republic of China. The company offers IVD products, which utilize ECLIA technology, fluorescent in situ hybridization (FISH) technology, and surface plasmon resonance (SPR) technology to detect and monitor various diseases and disorders through the laboratory evaluation and analysis of blood, urine, or other body fluids. It offers ECLIA system, which includes ECLIA analyzer for detecting the minute levels of light triggered by combining reagents with body fluid samples to produce diagnostic results; and reagent kits for detecting and monitoring various types of diseases and disorders, including thyroid disorders, diabetes, hepatitis, SARS, Down syndrome, liver fibrosis, disorders related to reproduction and growth, and various types of tumors. The company also provides FISH imaging analysis system that enables medical practitioners to visualize and locate DNA sequences in human cells for identifying chromosomal abnormalities, using FISH technology; and offers FISH probes used for prenatal and cancer management. The FISH probes are used for the detection and monitoring the course of bladder cancer; treatment of breast cancer; prediction and diagnosis of cervical cancer; diagnosis and prognosis of various leukemias and multiple myeloma; detection of epidermal growth factor receptor abnormalities; detection of Trisomy 21, Trisomy 18, Trisomy 13, Turner syndrome, Trisomy X, XYY syndrome, DiGeorge syndrome, and triploidy; and diagnosis of prostate cancer. In addition, it offers HPV-DNA chips and SPR-based analysis system for the diagnosis of human papillomavirus (HPV) infection and genotyping of HPV. The company sells its products through distributors. China Medical Technologies, Inc. was founded in 1999 and is based in Beijing, the Peoples Republic of China.
AETERNA ZENTARIS INC (NASDAQ:AEZS) - terna Zentaris Inc. operates as a late-stage drug development company specialized in oncology and endocrinology. Its lead oncology compounds include perifosine, an orally active PI3K/Akt pathway inhibitor that is in Phase III registration trial for multiple myeloma; and AEZS-108, a doxorubicin-targeted conjugate in Phase II for the treatment of advanced ovarian and endometrial cancer. The companys lead endocrinology compound, AEZS-130, is an oral ghrelin antagonist in Phase III trial as a diagnostic test for Adult Growth Hormone Deficiency. Its pipeline also includes earlier-stage compounds, such as AEZS-112 that is in a Phase I trial in advanced solid tumors and lymphoma, as well as AEZS-120, an anti-cancer vaccine in pre-clinical development. The company was founded in 1991 and is headquartered in Quebec City, Canada.
ALBANY MOLECULAR RESEARCH (NASDAQ:AMRI) - Albany Molecular Research, Inc. provides contract services to various pharmaceutical and biotechnology companies primarily in the United States, Europe, and Asia. The company offers drug discovery services, including assay development and design; screening programs, which provide tools to identify active compounds during the lead discovery phases of drug discovery; screening libraries for screening and hit-to-lead programs; bioanalytical services for extraction and quantitation of drug and metabolites in biological fluids and tissues; and natural product services. Its drug discovery services also include medicinal chemistry; computer-aided drug discovery services to identify novel hits or leads against selected therapeutic targets, as well as to support medicinal chemistry lead optimization programs; and in vitro ADMET assays to evaluate and improve metabolism, bioavailability, pharmacology, and toxicology of compounds. The company also provides chemical development services, such as process research and development; custom synthesis; process safety assessment; high potency and controlled substances; preparative chromatography; IND support services; fermentation development and optimization; and building blocks collection and database, as well as offers chemical synthesis and manufacturing services in accordance with cGMP regulations, and formulation services. In addition, it provides analytical services, including impurity identification and structure elucidation; method development, qualification, and validation; preformulation and physical characterization; quality control; stability services; and regulatory support, as well as offers chemical synthesis and manufacturing services. The company also serves agricultural and fine chemical companies, contract chemical manufacturers, government research entities, and non-profit organizations. Albany Molecular Research was founded in 1991 and is based in Albany, New York.
MEMC ELECTRONIC MATERIALS (NYSE:WFR) - MEMC Electronic Materials, Inc. engages in the development, manufacture, and sale of silicon wafers for the semiconductor industry worldwide. Its wafers are used as the starting material for the manufacture of various types of semiconductor devices, including microprocessor, memory, logic, and power devices. The company operates in three segments: Semiconductor Materials, Solar Materials, and Solar Energy. The Semiconductor Materials segment offers prime polished wafers, such as OPTIA and annealed products; epitaxial wafers consisting of thin silicon layer grown on the polished surface of the wafer; test/monitor wafers for testing semiconductor fabrication lines and processes; and silicon-on-insulator wafers used for the chip making process. The Solar Materials segment provides solar wafers that are used as the starting material for crystalline solar cells. The Solar Energy segment offers solar energy services that integrate the design, installation, financing, monitoring, operations, and maintenance portions of the downstream solar market. As of December 31, 2010, it interconnected approximately 393 solar power system systems representing 267 megawatt of solar energy generating capacity. In addition, the company develops and sells photovoltaic energy solutions. Its customers comprise semiconductor device manufacturers, including the memory, microprocessor, and ASIC manufacturers; and foundries, solar cell and module manufacturers, and flat panel display producers and other industries. The company also serves commercial customers, such as large, national retail chains, and real estate property management firms; federal, state, and municipal governments; and utilities. It markets its solar energy generation, monitoring, and maintenance services through a direct sales force, as well as through solar channel partners. The company was founded in 1984 and is based in St. Peters, Missouri.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641